T11	Effect 0 30;157 290	Neuroleptic malignant syndrome muscular rigidity, hyperthermia, autonomic dysfunction, altered consciousness, high creatinine phosphokinase levels, and leukocytosis
T12	Treatment 95 114	antipsychotic drugs
T13	Speculation_cue 50 61	potentially
T16	Drug 95 108	antipsychotic
T17	Severity_cue 62 67	fatal
T15	Adverse_event 83 91	reaction
E1	Adverse_event:T15 
A1	Severity E1 High